Phase II Clinical Trial Using Humira in Netherton Syndrome
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Congenital ichthyosiform erythroderma
- Focus Therapeutic Use
- Acronyms AntiTNF-SN
- 16 Oct 2017 Status changed from active, no longer recruiting to completed.
- 11 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 27 Jun 2016 Status changed from recruiting to active, no longer recruiting.